ACS	American Cancer Society
ADT	Androgen deprivation therapy
ATM	Ataxia telangiectasia mutated
BRCA1	Breast cancer gene 1
BRCA2	Breast cancer gene 2
BRIP1	BRCA-interacting protein C-terminal helicase 1
CHEK2	Checkpoint kinase 2
EAU	European Association of Urology
EPCAM	Epithelial cell adhesion molecule
FDA	Food and Drug Administration
FRR	Familial relative risk
GWAS	Genome-wide association studies
HBOC	Hereditary breast and ovarian cancer
HNPCC	Hereditary nonpolyposis colorectal cancer
HOXB13	Homeobox B13
HPC	Hereditary prostate cancer
HR	Homologous recombination
LS	Lynch Syndrome
mCRPC	Metastatic castration-resistant PrCa
MLH1	MutL homologue 1
MMR	Mismatch repair
MSH2	MutS homologue 2
MSH6	MutS homologue 6
MSI-H	Microsatellite instability-high
NBN	Nibrin
NBS1	Nijmegen Breakage Syndrome 1
NCCN	National Comprehensive Cancer Network
PALB2	Partner and localizer of BRCA2
PARP	Poly(adenosine diphosphate-ribose) polymerase
PD-1	Programmed cell death protein-1 ligand
PMS2	Postmeiotic segregation increased
PrCa	Prostate cancer
PSA	Prostate-specific antigen
RR	Relative risk